Loading...
UK Trademark — IPO
PHARMAGENE INDICATION SWITCH
Application UK00002261007 · Dead
Quick Facts
| Application Number | UK00002261007 |
| Status | Dead |
| Owner | Asterand UK Limited |
| Filed | 2001-02-12 |
| Registered | 2003-12-19 |
| Renewal Due | 2011-02-12 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Is this trademark active?
PHARMAGENE INDICATION SWITCH has a current status of Dead.
Goods & Services
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Class 9 — Electrical & IT
Computer software; computer software for use in pre-clinical, clinical and pharmaceutical research; computer databases for use in drug discovery and drug research; computer databases for research into human gene distribution and function; electronic publications relating to pre-clinical, clinical and pharmaceutical research.
Class 16 — Paper & Printed Matter
Printed matter; printed publications; books; reports, manuals, research and information documents; publications relating to drug discovery programs, pre-clinical and clinical screening programs and to pharmaceutical research programs; educational and teaching materials relating to pre-clinical, clinical and pharmaceutical research; computer manuals and computer handbooks for use with computer databases.
Class 42 — Scientific & IT Services
Drug discovery services; pharmaceutical research services; pre-clinical screening, and clinical research and evaluation services; bioinformatics, genomics, proteomics and pharmacology research services; development of human disease models for use in evaluation of drugs and discovery of new drugs; drug discovery, drug screening, pre-clinical, and pharmaceutical programs; compilation of databases for use in pharmaceutical research; compilation of databases for use in research into human gene and human protein functions; design of computer models for use in pre-clinical, clinical and pharmaceutical research; collection and maintenance of data for study of genomes; collection and maintenance of genetic information including gene form and gene function; consultancy, information and advisory services for all the aforesaid services.
Timeline
- Filed: 2001-02-12
- First published: 2003-09-05 (Journal 6496)
- Registered: 2003-12-19
- Renewal due: 2011-02-12
About This Trademark
'PHARMAGENE INDICATION SWITCH' is a dead trademark on the UK IPO register, owned by Asterand UK Limited. The application (UK00002261007) was filed on 12 February 2001 and registered on 19 December 2003. The registration is set to expire on 12 February 2011.
This mark is recorded under multiple classes: Class 9 (scientific, electrical & IT apparatus); Class 16 (paper, cardboard & printed matter); Class 42 (scientific, IT & design services).
The trademark is represented by HGF Limited.
Frequently Asked Questions
Who owns UK trademark UK00002261007 ('PHARMAGENE INDICATION SWITCH')?
UK trademark UK00002261007 for the mark 'PHARMAGENE INDICATION SWITCH' in Class 9, 16, 42 is recorded on the UK IPO register as owned by Asterand UK Limited. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Is UK trademark UK00002261007 currently a registered trademark?
No — the UK IPO records the status of UK trademark UK00002261007 for the mark 'PHARMAGENE INDICATION SWITCH' as dead.
Which Nice classes is UK trademark UK00002261007 registered under?
UK trademark UK00002261007 for the mark 'PHARMAGENE INDICATION SWITCH' is recorded in Class 9 (scientific, electrical & IT apparatus); Class 16 (paper, cardboard & printed matter); Class 42 (scientific, IT & design services). The filed specification reads: Class 9: Computer software; computer software for use in pre-clinical, clinical and pharmaceutical research; computer databases for use in drug discovery and drug research; computer databases for research into human gene distribution and function; electronic publications relating to pre-clinical, clinical and pharma…
When was UK trademark UK00002261007 filed?
UK trademark UK00002261007 for the mark 'PHARMAGENE INDICATION SWITCH' was filed at the UK IPO on 12 February 2001 and registered on 19 December 2003.
When was UK trademark UK00002261007 published?
The UK IPO first published / advertised UK trademark UK00002261007 for the mark 'PHARMAGENE INDICATION SWITCH' on 5 September 2003.
When does UK trademark UK00002261007 need to be renewed?
UK trademark UK00002261007 for the mark 'PHARMAGENE INDICATION SWITCH' is currently recorded as valid until 12 February 2011, at which point it will need to be renewed with the UK IPO to remain in force.
Attorney of Record
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Data Source
United Kingdom (Intellectual Property Office)
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.